Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Methotrexate for Induction of Remission in Refractory Crohn's Disease: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433010/all/Low_level_laser_therapy_for_treating_tuberculosis_Unchanged. Accessed 28 March 2024.
Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433010/all/Low_level_laser_therapy_for_treating_tuberculosis_Unchanged. Accessed March 28, 2024.
Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433010/all/Low_level_laser_therapy_for_treating_tuberculosis_Unchanged
Methotrexate for Induction of Remission in Refractory Crohn's Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433010/all/Low_level_laser_therapy_for_treating_tuberculosis_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review
ID - 433010
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433010/all/Low_level_laser_therapy_for_treating_tuberculosis_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -